The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,961.89 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Tata Equity P/E Fund - (G) 195.45 16,65,000 2.42 Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 195.45 16,65,000 2.42 Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5% ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals NV have received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market a product for the treatment of ...

Welcome to Fierce Pharma's regulatory tracker for the first ... Be sure to come back regularly for the latest updates. The drug is the first once-monthly treatment targeting factor XIIa to prevent ...